Results 181 to 190 of about 11,686 (228)

Peritoneal carcinomatosis from colorectal cancer: HIPEC?

Surgical Oncology, 2007
Peritoneal carcinomatosis (PC) is a frequent terminal evolution from colorectal cancer. At the time of diagnosis of colon malignancies, PC affects approximately 10% of the patients [1]. Medical oncologists and gastrointestinal surgeons had considered it to be an untreatable condition for its unfavorable prognosis with a median survival of 6-9 months [1]
G, Confuorto, M E, Giuliano, A, Grimaldi, C, Viviano   +3 more
openaire   +2 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer

Journal of Obstetrics and Gynaecology Research, 2020
AbstractAimHyperthermic intraperitoneal chemotherapy (HIPEC) is a method of administering anticancer agents directly while heating the abdominal cavity. The aim of this review is to know the current position of HIPEC in ovarian cancer and uterine sarcoma and its future prospects.MethodsThis article reviews the current literature and evidence for the ...
Hideaki, Tsuyoshi, Daisuke, Inoue, Tetsuji, Kurokawa, Yoshio, Yoshida   +3 more
openaire   +2 more sources

Anästhesiologisches Vorgehen bei HIPEC

Journal Club AINS, 2013
Zytoreduktive Chirurgie in Kombination mit hyperthermer intraperitonealer Chemotherapie (HIPEC) ist bei bestimmten Malignomen mit Beteiligung des Peritoneums ein vielversprechender Behandlungsweg. Fur den Anasthesisten ist dieses Verfahren eine multimodale Herausforderung mit dem Ziel eines optimalen perioperativen Managements. Einen Uberblick uber die
openaire   +1 more source

Liver Resection and HIPEC

2019
Synchronous intra-parenchymal hepatic involvement (HI) in patients with peritoneal disease (PD) has traditionally served as a contraindication for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, several studies have demonstrated the feasibility and safety of combined liver resection with CRS/HIPEC in well ...
Laura M. Enomoto, Edward A. Levine, Perry Shen, Konstantinos I. Votanopoulos   +3 more
openaire   +1 more source

HIPEC + EPIC versus HIPEC‐alone: Differences in major complications following cytoreduction surgery for peritoneal malignancy

Journal of Surgical Oncology, 2012
AbstractIntroductionPeritoneal metastases (PM) can be treated with cytoreduction surgery (CRS) with intraoperative heated intraperitoneal chemotherapy (HIPEC) plus or minus early postoperative intraperitoneal chemotherapy (EPIC). HIPEC + EPIC may be associated with more complications than HIPEC alone.MethodsA prospective database of consecutive ...
Yarrow J, McConnell, Lloyd A, Mack, Wesley P, Francis, Thomas, Ho, Walley J, Temple   +4 more
openaire   +2 more sources

HIPEC for colorectal peritoneal metastases

The Lancet Oncology, 2021
Samuel J, Klempner, David P, Ryan
openaire   +2 more sources

HIPEC

2023
Shadin Ghabra, Andrew M. Blakely, Andrew Mannes, Ning Miao   +3 more
openaire   +1 more source

?????????????????????????????? ?? ?????????????????????????????? ?????????????? ?????? ???????????????????? ?????????????????? HIPEC ?? ???????????????????????????? ???????????????????? ?????? ???????????????????????????? ??????????????????????????

2018
?????????????????? ???????????????? ???????????????????????? ?????????????????????????????? ?? ?????????????????????????????? ?????? ???????????????????? ?????????????????? HIPEC ?? ???????????????????????????? ???????????????????? ?????? ?????????????????????????? ??????????????. ????????????????, ?????? ?????????????? ???????????????? ?? ?????????????
openaire   +1 more source

HIPEC, een nieuwe chirurgische techniek

2013
Chirurgie is de hoeksteen van de behandeling van kanker; bij veel maligne tumoren is genezing alleen mogelijk als ze volledig chirurgisch verwijderd worden. Met steeds verfijndere chirurgische technieken is het gelukt de overlevingskansen te vergroten en de morbiditeit van de behandeling te verkleinen.
Patrick Hemmer, Barbara van Leeuwen
openaire   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials

ESMO Open, 2022
Konstantinos K Tsilidis
exaly